Cargando…
A novel technique of serial biopsy in mouse brain tumour models
Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments can be appropriately tailored. Dacomitinib (PF-00299804) is a tyrosine kinase inhibitor (TKI), which is predicted to only be effective in cancers where the targets of this drug (EGFR, ERBB2, ERBB4) are abnorma...
Autores principales: | Rogers, Sasha, Hii, Hilary, Huang, Joel, Ancliffe, Mathew, Gottardo, Nick G., Dallas, Peter, Lee, Sharon, Endersby, Raelene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386264/ https://www.ncbi.nlm.nih.gov/pubmed/28394918 http://dx.doi.org/10.1371/journal.pone.0175169 |
Ejemplares similares
-
RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN
por: Buck, Jessica, et al.
Publicado: (2020) -
Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021) -
Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets
por: Abbas, Zahra, et al.
Publicado: (2022) -
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018) -
Correction: A novel technique of serial biopsy in mouse brain tumour models
Publicado: (2019)